Skip to main content
. 2025 Mar 28;53(5):100074. doi: 10.1016/j.dmd.2025.100074

Table 5.

Analysis of potential DDIs in accordance with the Food and Drug Administration recommendations. Critical interactions exceeding the cutoff of R ≥ 1.1 are highlighted in bold

Perpetrator
Fenoterol Sumatriptan Ipratropium Trospium Metformin Quinidine Verapamil Trimethoprim
Victim drug Fenoterol 1.00 1.00 1.00 1.00 1.17 1.18 1.19
Salbutamol 1.00 1.00 1.00 1.01 1.00 1.45 1.53 1.23
Sumatriptan 1.00 1.00 1.00 1.01 1.11 1.09 1.71
Zolmitriptan 1.00 1.00 1.00 1.01 1.00 1.32 1.60 1.24
Ipratropium 1.00 1.01 1.01 1.01 1.10 1.09 1.79
Trospium 1.00 1.01 1.00 1.00 1.15 1.13 1.46
Methylnaltrexone 1.00 1.00 1.00 1.01 1.01 1.32 1.29 1.45
Metformin 1.00 1.00 1.00 1.01 1.25 1.30 1.20

DDI, drug-drug interaction; R, drug drug interaction risk.